Search Results 751-760 of 17362 for Teratogenic

1. Multi-Center Prospective Validation Study of VTE Risk Prediction Tool in Trauma Patients - Mayo Clinic

   Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease. Massive bleeding from injury ...

2. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

   Learn how genetic testing can help customize your cancer treatment plan. Precision medicine is improving breast cancer diagnosis, treatment and prevention.

3. A Study to Identify Genes Responsible for Venous Thromboembolism (VTE) in Families - Mayo Clinic

   The purpose of this study is to identify susceptibility genes for venous thromboembolism (VTE) using conventional and novel genetic-epidemiologic methods in ...

4. A Study of Effect of Temporary Sympatholysis on Ventricular Arrhythmic Trigger and Substrate - Mayo Clinic

   This study is being done to determine whether there is an increase in sympathetic nerve activity before the onset of ventricular arrhythmias. Participation ...

5. Oncology (Medical) - Clinical trials

   Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

6. A Study of the Effect of Lack of Sleep on Blood Pressure - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

7. Clinical trials - Transplant Center

   The purpose of this study is to compare functional improvement and caregiver burden pre- and post-liver transplant (LT) in four patient and patient's ...

8. Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients with Brain Metastases that have been Removed by Surgery - Mayo Clinic

   About this study. RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue.

9. Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma - Mayo Clinic

   RATIONALE: Lenalidomide may stimulate the immune system in different ways and stop cancer cells from growing. Monoclonal antibodies, such as rituximab, can ...

10. EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway - Mayo Clinic

    About this study. The purpose of this trial is to evaluate the proportion of obese patients who respond to setmelanotide at 52 weeks of treatment.